Healthcare leaders today are inundated with data. Dashboards capture patient flow, cost trends, utilization, revenue cycle performance, and more. At first glance, this level of visibility feels like progress. But …
Health
-
-
Garner Health, a digital platform connecting patients with high-performing providers, announced Thursday that it has raised $100 million in Series E funding. The company serves employers and has a dataset …
-
Health
Pfizer’s $10.5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing
Pfizer is the latest big pharmaceutical company turning to China for biotechnology innovation, striking up a cancer R&D agreement spanning a dozen drugs that will be developed under a partnership …
-
This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive …
-
Doctor visits. Referrals. Labs. Scripts. Wearables. We’ve built a healthcare system that produces an astonishing amount of information but somehow still struggles to generate clarity. As a system of record …
-
AbbVie’s strategy of growing in oncology by focusing on a particular type of targeted therapy is paying off with another FDA approval, this time for a drug developed for an …
-
The Centers for Medicare and Medicaid Services finalized a new rule on Thursday to improve the federal independent dispute resolution (IDR) process under the No Surprises Act. The update is …
-
Teladoc Health’s services are now available through Walmart’s Better Care Services platform, the companies announced on Thursday. Through Walmart Better Care Services, customers can compare and access virtual care services …
-
Welcome back to another episode of MedCity FemFwd, a podcast dedicated to exploring the breakthroughs and challenges in women’s health. In this episode, we’re joined by Janna Manjelievskaia, director of …
-
Apogee Therapeutics’ lead drug candidate has new mid-stage data indicating it could be competitive with currently available biologic medicines for atopic dermatitis, but with less frequent injections. Now the biotech …